Date | Company | Who recommends | Recommendation | Target price |
---|---|---|---|---|
Boston Scientific Corporation | Deutsche Bank | Buy | 22 | |
Pfizer Inc. | Morgan Stanley | Buy | 43 | |
Abbott Laboratories | Barclays | Buy | 52 | |
Mylan N.V. | Barclays | Buy | 57 | |
PerkinElmer Inc. | UBS | Buy | 60 | |
Merck & Co. Inc. | UBS | Buy | 68 | |
DENTSPLY International Inc. | Morgan Stanley | Buy | 70 | |
St. Jude Medical Inc. | Deutsche Bank | Buy | 77 | |
AbbVie Inc. | UBS | Buy | 78 | |
Bristol-Myers Squibb Company | Morgan Stanley | Buy | 80 | |
Mallinckrodt Public Limited Company | Barclays | Buy | 80 | |
DaVita HealthCare Partners Inc. | RBC Capital Mkts | Buy | 83 | |
Endo International plc | Deutsche Bank | Buy | 88 | |
HCA Holdings, Inc. | UBS | Buy | 90 | |
Eli Lilly and Company | BofA/Merrill | Buy | 90 | |
Express Scripts Holding Company | RBC Capital Mkts | Buy | 95 | |
Johnson & Johnson | Deutsche Bank | Buy | 105 | |
CVS Health Corporation | Deutsche Bank | Buy | 118 | |
Stryker Corporation | Argus | Buy | 120 | |
Gilead Sciences Inc. | Deutsche Bank | Buy | 124 |